Convergent neurobiological studies of valuebased learning, and the computational models that flow from them, have long pointed to the existence of a reciprocal relationship between dopamine and beliefs. The complex interactions between the pharmacological (reinforcing) effects of addictive drugs and the conditioned responses (expectations) engendered by their continued use (1, 2) provide some of the most compelling examples of this dialogue between molecules and cognition. They help explain, among others, why drug abusers perceive the drug as more pleasurable when they expect it relative to when they do not (3, 4). The report by Gu et al. in PNAS (5) represents an important step forward in this context because it offers new insights into how the power of belief modulates nicotine-driven learning signals related to nondrug rewards (money), as well as non-drug-related decisions (choice behavior). More specifically, this work illuminates the mechanisms whereby belief can influence nonconscious learned association by modulating how the brain performs risk decisions while under the effects of nicotine.To investigate how pertinent beliefs can influence the brain's response to value-based learning and behavioral choices, the authors combined functional MRI with a task that involves two computationally explicit variables (one passive and market dependent and the other choice dependent) suitable for probing the inner workings of dopaminergic-driven learning processes. When subjects expected and received nicotine in their cigarettes, they displayed a much larger activation in the ventral striatum (brain reward region modulated by dopamine) in response to either market value or to prediction reward error signals than after receiving nicotine when it was not expected. These attenuated patterns of ventral striatal activation led in turn to a diminished influence of the corresponding neural representations (of either the market value or reward prediction error) on future bets (choice behavior). Thus, expectation about the presence of nicotine influenced not only the responses to drugs (as had been shown previously) but also the brain response to the value of a nondrug reward, as well as the choice of behavior intended to maximize it (Fig. 1).These new insights expand the importance of learning and memory in responses to drugs of abuse beyond that of conditioned responses to the drug and to drug-associated cues, to include conditioning to behaviors that occur while under the influence of the drug. For example, conditioning to the dopamine-mediated drug effects on biasing choices toward larger riskier rewards rather than smaller certain ones (6) could underlie the influence of belief in the behavioral choices while under the influence of nicotine reported by Gu et al. (5). These results have far reaching clinical implications. Drugs (including nicotine), by acutely increasing dopamine levels, temporarily enhance the salience value of other stimuli (7); thus, the conditioning to these effects will contribute to drug reinforcemen...